Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 14, 2011; 17(14): 1889-1894
Published online Apr 14, 2011. doi: 10.3748/wjg.v17.i14.1889
Published online Apr 14, 2011. doi: 10.3748/wjg.v17.i14.1889
Characteristics | Group 1 | Group 2 | χ2 | P-value | |
Sex | Female | 11 (17.46) | 96 (13.66) | 0.6964 | > 0.05 |
Male | 52 (82.54) | 607 (86.34) | |||
Age (yrs) | ≤ 30 | 3 (4.76) | 17 (2.42) | 1.2490 | > 0.05 |
30-60 | 48 (76.19) | 549 (78.09) | |||
> 60 | 12 (19.05) | 137 (19.49) | |||
Child-Pugh score | Class A | 62 (98.41) | 692 (98.44) | 0.0002 | > 0.05 |
Class B | 1 (1.59) | 11 (1.56) | |||
Cirrhotic nodule | No | 7 (11.11) | 121 (17.21) | 1.5462 | > 0.05 |
Yes | 56 (88.89) | 582 (82.79) | |||
HBsAg | Negative | 8 (12.70) | 90 (12.80) | 0.0006 | > 0.05 |
Positive | 55 (87.30) | 613 (87.20) | |||
ALT level1, U/L | ≤ 80 | 57 (90.48) | 621 (88.34) | 0.2605 | > 0.05 |
> 80 | 6 (9.52) | 82 (11.66) | |||
GGT level1, U/L | ≤ 60 | 24 (38.10) | 367 (52.20) | 4.6062 | < 0.05 |
> 60 | 39 (61.90) | 336 (47.80) | |||
AFP level, ng/mL | ≤ 20 | 8 (12.70) | 259 (36.84) | 16.0745 | < 0.01 |
20-400 | 20 (31.75) | 192 (27.31) | |||
≥ 400 | 35 (55.56) | 252 (35.85) | |||
Tumor size2, cm | ≤ 2 | 3 (4.76) | 82 (11.66) | 23.3257 | < 0.01 |
2-5 | 19 (30.16) | 333 (47.37) | |||
5-8 | 15 (23.81) | 166 (23.61) | |||
> 8 | 26 (41.27) | 122 (17.35) | |||
Capsule | complete/present | 31 (49.21) | 390 (55.48) | 0.9183 | > 0.05 |
incomplete/absent | 32 (50.79) | 313 (44.52) | |||
Microvascular invasion | No | 30 (47.62) | 472 (67.14) | 9.7556 | < 0.01 |
Yes | 33 (52.38) | 231 (32.86) | |||
Tumor number | solitary nodule | 49 (77.78) | 597 (84.92) | 3.8413 | > 0.05 |
2 nodules | 13 (20.63) | 86 (12.23) | |||
3 nodules | 1 (1.59) | 20 (2.84) | |||
Cell differentiation grade | GradeI-II | 41 (65.08) | 506 (71.98) | 1.3475 | > 0.05 |
Grade III-IV | 22 (34.92) | 197 (28.02) | |||
pTNM staging | Stage I | 21 (33.33) | 409 (58.18) | 15.1735 | < 0.01 |
Stage II | 34 (53.97) | 250 (35.56) | |||
Stage III A | 8 (12.70) | 44 (6.26) | |||
BCLC classification | Stage A | 49 (77.78) | 607 (86.34) | 3.4501 | > 0.05 |
Stage B | 14 (22.22) | 96 (13.66) |
Risk factor | Coefficient | OR (95% CI) | P-value | |
AFP level (ng/mL) | ≤ 20 = 0 | 0.52 | 1.68 (1.20-2.36) | < 0.01 |
20-400 = 1 | ||||
> 400 = 2 | ||||
Tumor size (cm) | ≤ 2 = 0 | 0.55 | 1.73 (1.29-2.31) | < 0.01 |
2-5 = 1 | ||||
5-8 = 2 | ||||
> 8 = 3 | ||||
Microvascular invasion | No = 0 | 0.65 | 1.91 (1.12-3.24) | 0.02 |
Yes = 1 |
- Citation: Chen XH, Zhang BH, Xin Y, Ren ZG, Fan J, Qiu SJ, Zhou J. Risk factors for residual tumor after resection of hepatocellular carcinoma. World J Gastroenterol 2011; 17(14): 1889-1894
- URL: https://www.wjgnet.com/1007-9327/full/v17/i14/1889.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i14.1889